A detailed history of Bbr Partners, LLC transactions in Novo Nordisk A S stock. As of the latest transaction made, Bbr Partners, LLC holds 1,798 shares of NVO stock, worth $188,897. This represents 0.02% of its overall portfolio holdings.

Number of Shares
1,798
Previous 1,798 -0.0%
Holding current value
$188,897
Previous $256,000 16.41%
% of portfolio
0.02%
Previous 0.02%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 05, 2024

SELL
$122.71 - $146.91 $49,697 - $59,498
-405 Reduced 18.38%
1,798 $256,000
Q4 2023

Feb 12, 2024

BUY
$87.78 - $105.45 $193,379 - $232,306
2,203 New
2,203 $227,000
Q1 2020

May 14, 2020

SELL
$49.46 - $64.78 $500,980 - $656,156
-10,129 Closed
0 $0
Q4 2019

Feb 14, 2020

BUY
$49.86 - $58.26 $505,031 - $590,115
10,129 New
10,129 $586,000

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $237B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Bbr Partners, LLC Portfolio

Follow Bbr Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bbr Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Bbr Partners, LLC with notifications on news.